Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormones — hormones chemically identical to human hormones (most commonly 17β‑estradiol and micronized progesterone) — can be an effective treatment for menopause symptoms, but they carry the same potential benefits and risks as conventional hormone therapy. Major medical organizations do not consider “bioidentical” medications inherently safer just because of that label, and they warn against unregulated compounded products and unsupported testing.

What doctors and major organizations say

• North American Menopause Society (NAMS), Endocrine Society, ACOG and the FDA: accept the use of bioidentical hormones when appropriate, but emphasize individualized risk–benefit assessment. They recommend FDA‑approved products whenever possible and caution about claims that compounded “BHRT” is safer or more natural.
• FDA: warns that the term “bioidentical” is a marketing term and that compounded versions aren’t FDA‑approved—so potency, purity and dosing can be inconsistent.
• Many clinicians: are comfortable using FDA‑approved estradiol and micronized progesterone (which are bioidentical chemically) but are cautious about compounded formulations and about salivary hormone testing (saliva tests are not reliable for guiding dosing).

Safety and risks (what to consider)

• Benefits: effective for hot flashes, vaginal dryness, sleep problems and bone protection in symptomatic women.
• Risks: increased risk of venous thromboembolism (VTE), stroke and, with combined estrogen+progestin regimens, a possible increase in breast cancer risk seen in some studies (risk varies by duration, dose, route and type of progestogen).
• Route and formulation matter: transdermal estradiol (patches, gels) appears to have lower VTE risk than oral estrogen in some studies. Micronized progesterone may have a more favorable breast and cardiovascular profile than some synthetic progestins, though data are not definitive.
• Compounded BHRT: can be useful in specific circumstances (allergy to an excipient, need for an unusual dose or delivery form), but lacks the batch testing, labeling and clinical trials of FDA‑approved products. There have been reports of incorrect potency or contamination.

Practical guidance doctors usually give

• Get a individualized risk assessment (personal/family history of breast cancer, blood clots, stroke, heart disease, liver disease).
• Prefer FDA‑approved bioidentical products when possible.
• Use the lowest effective dose for the shortest time needed, and reassess regularly.
• Avoid relying on saliva hormone tests to dose therapy; blood levels are sometimes checked for specific reasons but symptoms and side effects are the main guide.
• If using compounded BHRT, use a reputable compounding pharmacy (look for accreditation such as USP or PCAB) and ensure your prescriber documents why an FDA‑approved product isn’t suitable.

Examples of FDA‑approved products (commonly used and why doctors choose them)

• Estradiol patches: Vivelle‑Dot, Climara — transdermal delivery, often preferred for lower VTE risk and steady dosing.
• Estradiol gels: EstroGel, Divigel — another transdermal option for systemic estrogen.
• Oral estradiol: Estrace — an FDA‑approved oral estradiol option.
• Micronized progesterone: Prometrium — bioidentical progesterone approved for women who need progestogen with estradiol to protect the uterus. (These names are examples of FDA‑approved formulations; your clinician will pick the best formulation and dose for you.)

When BHRT might be especially indicated

• Moderate to severe menopausal symptoms interfering with quality of life.
• Women at low risk from hormones and/or after counseling about risks and benefits.
• Cases where FDA‑approved options aren’t suitable and a carefully compounded product is necessary.

Bottom line Bioidentical hormones themselves (estradiol, progesterone) are not intrinsically safer or risk‑free solely because they are “bioidentical.” Many doctors use FDA‑approved bioidentical hormones and consider them appropriate and safe for many patients when individualized and monitored. Be cautious about compounded BHRT and clinics that use marketing claims like “natural cure” or rely on saliva tests. Talk with a gynecologist, menopause specialist or endocrinologist to review your personal risks and goals before starting BHRT.

If you want, I can:

• Help you draft questions to ask your clinician,
• Summarize differences between a few specific products for your situation, or
• Look up current guideline statements from NAMS, ACOG or the Endocrine Society.